speb/financial-data huggingface dataset:
ACM.AX income_statement (annual, 2024-06-30) — Pretax Income: -2720642.00
ACM.AX balance_sheet (annual, 2024-06-30) — Receivables: 28385.00
ACM.AX income_statement (annual, 2024-06-30) — Reconciled Depreciation: 1790.00
ACM.AX cash_flow (annual, 2024-06-30) — Repayment Of Debt: -147005.00
ACM.AX cash_flow (annual, 2024-06-30) — Repurchase Of Capital Stock: -557966.00
ACM.AX balance_sheet (annual, 2024-06-30) — Retained Earnings: -5081714.00
ACM.AX income_statement (annual, 2024-06-30) — Salaries And Wages: -168000.00
ACM.AX income_statement (annual, 2024-06-30) — Selling And Marketing Expense: 89580.00
ACM.AX income_statement (annual, 2024-06-30) — Selling General And Administration: -78420.00
ACM.AX balance_sheet (annual, 2024-06-30) — Share Issued: 43531260.00
ACM.AX balance_sheet (annual, 2024-06-30) — Stockholders Equity: 2898993.00
ACM.AX balance_sheet (annual, 2024-06-30) — Tangible Book Value: 2898993.00
ACM.AX income_statement (annual, 2024-06-30) — Tax Effect Of Unusual Items: 0.00
ACM.AX income_statement (annual, 2024-06-30) — Tax Provision: 0.00
ACM.AX income_statement (annual, 2024-06-30) — Tax Rate For Calcs: 0.00
ACM.AX balance_sheet (annual, 2024-06-30) — Total Assets: 3053644.00
ACM.AX balance_sheet (annual, 2024-06-30) — Total Capitalization: 2898993.00
ACM.AX balance_sheet (annual, 2024-06-30) — Total Equity Gross Minority Interest: 2898993.00
ACM.AX balance_sheet (annual, 2024-06-30) — Total Liabilities Net Minority Interest: 154651.00
ACM.AX balance_sheet (annual, 2024-06-30) — Total Non Current Assets: 422968.00
ACM.AX balance_sheet (annual, 2024-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
ACM.AX balance_sheet (annual, 2024-06-30) — Working Capital: 2476025.00
ACM.AX income_statement (annual, 2025-06-30) — Basic Average Shares: 43883322.00
ACM.AX income_statement (annual, 2025-06-30) — Basic EPS: -0.03
ACM.AX income_statement (annual, 2025-06-30) — Diluted Average Shares: 43883322.00
ACM.AX income_statement (annual, 2025-06-30) — Diluted EPS: -0.03
ACMESOLAR.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -22842580000.00
ACMESOLAR.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 23497120000.00
ACMESOLAR.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -11510000.00
ACMESOLAR.NS income_statement (annual, 2022-03-31) — Amortization: 100000.00
ACMESOLAR.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 100000.00
ACMESOLAR.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 32010000.00
ACMESOLAR.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 3773920000.00
ACMESOLAR.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 457220000.00
ACMESOLAR.NS income_statement (annual, 2022-03-31) — Cost Of Revenue: 1562720000.00
ACMESOLAR.NS balance_sheet (annual, 2022-03-31) — Current Deferred Assets: 1132630000.00
ACMESOLAR.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 3640000.00
ACMESOLAR.NS cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: -3295630000.00
ACMESOLAR.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 408330000.00
ACMESOLAR.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 9325890000.00
ACMESOLAR.NS income_statement (annual, 2022-03-31) — Gross Profit: 13311350000.00
ACMESOLAR.NS balance_sheet (annual, 2022-03-31) — Hedging Assets Current: 20070000.00
ACMESOLAR.NS balance_sheet (annual, 2022-03-31) — Held To Maturity Securities: 215330000.00
ACMESOLAR.NS income_statement (annual, 2022-03-31) — Impairment Of Capital Assets: 0.00
ACMESOLAR.NS income_statement (annual, 2022-03-31) — Interest Income: 513080000.00
ACMESOLAR.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 513080000.00
ACMESOLAR.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 2829760000.00
ACMESOLAR.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 76740800000.00
ACMESOLAR.NS cash_flow (annual, 2022-03-31) — Net Investment Properties Purchase And Sale: 0.00
ACMESOLAR.NS cash_flow (annual, 2022-03-31) — Net Other Financing Charges: 619610000.00
ACMESOLAR.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Assets: 0.00
ACMESOLAR.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 2681990000.00
ACMESOLAR.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 20060000.00
ACMESOLAR.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 681830000.00
ACMESOLAR.NS cash_flow (annual, 2022-03-31) — Other Cash Adjustment Outside Changein Cash: -504640000.00
ACMESOLAR.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 320000.00
ACMESOLAR.NS balance_sheet (annual, 2022-03-31) — Other Payable: 2571450000.00
ACMESOLAR.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 3419950000.00
ACMESOLAR.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 62340000.00
ACMESOLAR.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 1298000000.00
ACMESOLAR.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
ACMESOLAR.NS cash_flow (annual, 2022-03-31) — Provisionand Write Offof Assets: -22300000.00
ACMESOLAR.NS cash_flow (annual, 2022-03-31) — Purchase Of Investment Properties: 0.00
ACMESOLAR.NS income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 1562720000.00
ACMESOLAR.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 2107850000.00
ACMESOLAR.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: -3431720000.00
ACMESOLAR.NS cash_flow (annual, 2022-03-31) — Sale Of Business: 0.00
ACMESOLAR.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 408330000.00
ACMESOLAR.NS balance_sheet (annual, 2022-03-31) — Taxes Receivable: 107910000.00
ACMESOLAR.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 766330000.00
ACMESOLAR.NS income_statement (annual, 2022-03-31) — Write Off: 0.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — +Operating Expense: 5488420000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — +Total Revenue: 12943970000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 621100000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 6992970000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -27744050000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 23545720000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -11170000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Amortization: 20000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 20000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 50000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 11490000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 605115540.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Basic EPS: -0.05
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 4784560000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 32010000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -7687830000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 3562020000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 1044420000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 4031150000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 11196190000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 1064520000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 2966630000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 824060000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 372680000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Change In Payable: -2110000000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Change In Receivables: 2321410000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: 1439330000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 689930000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Common Stock: 1044420000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 19005630000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 23123550000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 567620000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Current Assets: 27021390000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 308730000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Current Debt: 5580890000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 5889620000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Current Deferred Assets: 162760000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 130000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 9696030000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 390760000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Depreciation: 4848000000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 4848020000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 4848020000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 4848000000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 605115540.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Diluted EPS: -0.05
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: -31410000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — EBIT: 7876010000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — EBITDA: 12724030000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — End Cash Position: 5474490000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 2154260000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 4947000000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -225670000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -330000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 256020000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 300000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 7004140000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 117176710000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Gross Profit: 12376350000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Hedging Assets Current: 0.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Held To Maturity Securities: 215330000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Impairment Of Capital Assets: 0.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Interest Expense: 8030020000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 8030020000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Interest Income: 536150000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 536150000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -7493420000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 556720000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 105579120000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -14099160000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Investment Properties: 0.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 226820000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 19262110000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 2836480000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 3253290000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 80992600000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 84245890000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 19262110000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -7998450000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 31170000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 85963390000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 298990000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Minority Interests: 330000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: -929680000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Net Debt: 82542340000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -1680000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Net Income: -31410000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -31410000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -31740000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -31410000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -31410000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: -154010000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -31740000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Net Interest Income: -7555670000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Net Investment Properties Purchase And Sale: 0.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -4430650000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 9832350000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 11263660000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -7555670000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: 168690000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Net PPE: 89432660000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -7685040000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -1431310000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 19005330000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Assets: 73160000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 6588910000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 2475510000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 1981190000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 21720000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 1130650000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 12322990000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Normalized Income: -312138000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 12634830000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Operating Income: 6887930000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Operating Revenue: 12943970000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 605115540.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 323130000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 95930000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 6500000000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 300000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 7285760000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 112690000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 43010000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Other Payable: 2436010000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Other Properties: 5221280000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 5202840000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 7165040000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Other Special Charges: -399360000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Payables: 3057110000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 74650000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 738230000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Pretax Income: -154010000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: -9170000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Purchase Of Business: -929680000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -5536940000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment Properties: 0.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -7687830000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 567620000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 4848020000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -7998450000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 2305740000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: -3562320000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Sale Of Business: 0.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 1106290000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 2790000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 256020000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Share Issued: 605115540.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Special Income Charges: 399360000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 19005630000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 19005330000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 120312000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Tax Provision: -122270000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.30
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 99480000.00
ACMESOLAR.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -547420000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Total Assets: 121869530000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 99998230000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Total Debt: 90135510000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 19304620000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Total Expenses: 6056040000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 102564910000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 94848140000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 92868880000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 61800000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 401040000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 401040000.00
ACMESOLAR.NS balance_sheet (annual, 2023-03-31) — Working Capital: 17325360000.00
ACMESOLAR.NS income_statement (annual, 2023-03-31) — Write Off: 0.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — +Operating Expense: 4636310000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — +Total Revenue: 13188540000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 737580000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 4208850000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -22775280000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 24054780000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -5920000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Amortization: 20000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 20000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Assets Held For Sale Current: 126100000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 770000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 605115540.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Basic EPS: 11.53
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 5474490000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 32010000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -28226900000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 3187550000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 1044420000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 3091590000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 10806150000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 689760000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 2401830000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Change In Inventory: 0.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -9725420000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 10644870000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Change In Payable: 117990000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Change In Receivables: 2362390000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: 3412350000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -807320000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Common Stock: 1044420000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 25908690000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 0.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 30636570000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 619420000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Current Assets: 31553150000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 305550000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Current Debt: 5211650000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 5517200000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Current Deferred Assets: 92120000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Current Deferred Taxes Liabilities: 259690000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 14320790000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 392170000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Depreciation: 3081360000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 3081380000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 3081380000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 3081360000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 605115540.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Diluted EPS: 11.53
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 6977980000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — EBIT: 16665000000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — EBITDA: 19746380000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — End Cash Position: 3091590000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: 2157840000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -13885230000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -7212300000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -4520000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 334680000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 280000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 4214770000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 120976750000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Gross Profit: 12569120000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Hedging Assets Current: 0.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Held To Maturity Securities: 0.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Impairment Of Capital Assets: 75350000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Interest Expense: 7570750000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 7570750000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Interest Income: 1208580000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 1208580000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -6681550000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 1204800000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Inventory: 0.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 108084620000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -17306830000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Investment Properties: 14020000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 770000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 0.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 13422280000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 1865350000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 2882000000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 76964280000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 79846280000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 13246320000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -4209420000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 43720000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 83722450000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 40000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Minority Interests: 170000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: 11704040000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 0.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Net Debt: 79084340000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -510000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Net Income: 6977980000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 6977980000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 6977810000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 6977980000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 6977980000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 9094250000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 6977810000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Net Interest Income: -6396300000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Net Investment Properties Purchase And Sale: -14020000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -3563360000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 9212860000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 9036900000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -6396300000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: 200000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: -20000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Net PPE: 98201470000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -28020700000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 175960000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 25908410000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Assets: 143790000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 10702160000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 1928500000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 3154950000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 21380000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 604650000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 12317860000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Normalized Income: 1278246526.52
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 14341670000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Operating Income: 7932810000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Operating Revenue: 13188540000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 605115540.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Other Cash Adjustment Outside Changein Cash: -1575580000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 403680000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 94500000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 6500000000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 280000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 5960530000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: -15490000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 197560000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 630780000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Other Payable: 6654850000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Other Properties: 4720370000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 1448170000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 7714560000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Other Special Charges: -7503360000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Payables: 7392430000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 174390000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 10595230000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Pretax Income: 9094250000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: -140000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Purchase Of Business: -799590000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -4924230000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment Properties: -14020000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -28226900000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 0.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 619420000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 3081380000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 3480000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 3480000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -4209420000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 3841280000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 2831680000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Sale Of Business: 12503630000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 1360870000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 206200000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 334680000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Share Issued: 605115540.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Short Term Debt Issuance: 175960000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Special Income Charges: 7428010000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Stock Based Compensation: 0.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 25908690000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 25908410000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 1728786526.52
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Tax Provision: 2116440000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.23
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 31570000.00
ACMESOLAR.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -111660000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Total Assets: 133998010000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 102872970000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Total Debt: 85363480000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 25908730000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Total Expenses: 5255730000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 108089280000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 102444860000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 93768490000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 34130000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 7428520000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 7428520000.00
ACMESOLAR.NS balance_sheet (annual, 2024-03-31) — Working Capital: 17232360000.00
ACMESOLAR.NS income_statement (annual, 2024-03-31) — Write Off: 122280000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 1114750000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 3490120000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 536162679.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 2.09
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 696620000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 696620000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 536162679.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 2.09
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 1120580000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — EBIT: 2824490000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — EBITDA: 3521110000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 1790780000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 1790780000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Minority Interests: 0.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Net Income: 1120580000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 1120580000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 1120580000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 1120580000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 1120580000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 1120580000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -1790780000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -1790780000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 3590130000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 1168894000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Operating Income: 2375370000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 3490120000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 518140000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 251620000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 1033710000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 696620000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: -69020000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: -20706000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Tax Provision: -86870000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.30
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 1114750000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: -69020000.00
ACMESOLAR.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -69020000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — +Operating Expense: 4570140000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 1533600000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — +Total Revenue: 14051310000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 4868870000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 2247260000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 2247260000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 3808190000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 3808190000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -25709860000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -25709860000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 46690100000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 46690100000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -5920000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -5920000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Amortization: 20000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 20000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Assets Held For Sale Current: 96370000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 96370000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 613520000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 613520000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 554083516.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 573776744.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Basic EPS: 4.55
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 2.15
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 3091590000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 32010000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 32010000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -32659930000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 5530280000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 5530280000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 1210180000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1210180000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 12517460000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 12517460000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 21420720000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 21420720000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 1335800000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 1335800000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 11181660000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 11181660000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -39270000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: 1304030000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 873490000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Change In Payable: 1509290000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Change In Receivables: 400660000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: 4093220000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 9751140000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Common Stock: 1210180000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 1210180000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Common Stock Dividend Paid: 0.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 45105800000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 45105800000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 22932880000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 13676810000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 13676810000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 510750000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Current Assets: 37817460000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 37817460000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 481970000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 481970000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Current Debt: 5655310000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 5655310000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 6137280000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 6137280000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Current Deferred Assets: 110450000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Assets: 110450000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Current Deferred Taxes Liabilities: 1460000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Liabilities: 1460000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 13195300000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 13195300000.00
ACMESOLAR.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 1420840000.00
ACMESOLAR.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 1420840000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Depreciation: 2873130000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 2873130000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 2873130000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 1022200000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 2873130000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 1022200000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 556529801.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 576457944.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Diluted EPS: 4.53
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 2.14
ACMESOLAR.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 2521080000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 1233620000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — EBIT: 10972430000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — EBIT: 3718130000.00
ACMESOLAR.NS income_statement (annual, 2025-03-31) — EBITDA: 13845560000.00
ACMESOLAR.NS income_statement (quarterly, 2025-03-31) — EBITDA: 4740330000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — End Cash Position: 12842730000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 34082250000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -17229740000.00
ACMESOLAR.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 16820000.00